Quarterly report · Q2

Period2023-01-01 → 2023-06-30
Filed2023-08-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥2.1bn2023-01-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥1.2bn2023-04-01 → 2023-06-30dCons.Revenue IFRS
Revenue¥15.6bn2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.5bn2022-01-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥1.3bn2022-04-01 → 2022-06-30dCons.Revenue IFRS
Operating income−¥4.2bn2023-01-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income−¥2.2bn2023-04-01 → 2023-06-30dCons.Operating profit loss IFRS
Operating income−¥3.8bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income−¥1.6bn2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Profit before tax−¥3.8bn2023-01-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥1.9bn2023-04-01 → 2023-06-30dCons.Profit loss before tax IFRS
Profit before tax¥1.1bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥4.3bn2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥1.8bn2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Net income (owners)−¥2.1bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥658m2023-04-01 → 2023-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥382m2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥3.5bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥1.5bn2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥2.1bn2023-01-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥658m2023-04-01 → 2023-06-30dCons.Profit loss IFRS
Net income−¥3.5bn2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income−¥1.5bn2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Total assets¥104.1bnat 2023-06-30Cons.Assets IFRS
Total assets¥99.4bnat 2022-12-31Cons.Assets IFRS
Total assets¥91.2bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥41.4bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥41.5bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥62.7bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥57.9bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥56.4bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥57.5bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥62.7bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥57.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥56.4bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥65.6bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥66.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥53.7bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.1bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥3.0bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥10.0bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥3.2bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.8bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥1.0bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥183m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥107m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥4.9bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥4.8bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-25.132023-01-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-8.032023-04-01 → 2023-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥4.682022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-43.332022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-17.962022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-25.132023-01-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-8.032023-04-01 → 2023-06-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥4.632022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-43.332022-01-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-17.962022-04-01 → 2022-06-30dCons.Diluted earnings loss per share IFRS
Equity ratio60.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio58.3%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.8%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 560
ItemContextValueUnit
Notes segment information condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Description of fact that companys business comprises single segment IFRSCurrentYTDDuration
Original text (Japanese)当社グループは、医薬事業の単一セグメントであるため、記載を省略しています。
Notes financial instruments condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes share capital and other equity items condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes revenue condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes selling general and administrative expenses condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes earnings per share condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Notes subsequent events condensed quarterly consolidated financial statements IFRS (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass